Restasis

A Feasibility Study to Evaluate the Tolerability of Oph1 Compared to Restasis in Healthy Volunteers

Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% in a PROSE Device

Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)

Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome

Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes

Efficacy and Safety of HE10 for Dry Eye Syndrome

Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome

HU007 in Patients with Dry Eye Syndrome

Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis

Topical Cyclosporine and Disease Progression

Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease

A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®

Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?

Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%

Corneal Tear Film Imaging of the Cornea Before and After Restasis Therapy